Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Leonardo Muratori"'
Autor:
Leonardo Muratori, Paola Sperone, Gabriella Gorzegno, Anna La Salvia, Giorgio Vittorio Scagliotti
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 32, Iss 1, Pp 1-6 (2020)
Abstract Background Endometrial carcinoma is one of the most common female cancers in developed countries. Disease stage is associated with the risk of disease relapse after radical treatment. Typically, the risk of disease relapse peaks at 3 years f
Externí odkaz:
https://doaj.org/article/4cc5aef97a1d4c00b0dc342828a0d430
Autor:
Giorgio V. Scagliotti, Elena Trevisi, Massimo Di Maio, Anna La Salvia, Francesco Parisi, Francesco Atzeni, Maria Pia Brizzi, Leonardo Muratori
Publikováno v:
Acta Oncologica. 59:315-319
Publikováno v:
Critical Reviews in Oncology/Hematology. 139:41-52
Recurrent or metastatic head and neck squamous-cell carcinomas (R/M HNSCC) are a group of cancers with a very poor prognosis. Many clinical trials testing novel target therapies in this setting are currently ongoing. We performed a systematic review
Autor:
Massimo Di Maio, Elena Trevisi, Marco Donatello Delcuratolo, Leonardo Muratori, Paola Sperone
Publikováno v:
Expert review of anticancer therapy. 21(1)
Luteinized thecoma (thecomatosis) with sclerosing peritonitis (LTSP) is a very uncommon syndrome, characterized by the presence of single or bilateral ovarian thecomas and peritoneal fibrotic lesions. The disease occurs in young women and it can lead
Autor:
Anna La Salvia, Leonardo Muratori, Giorgio V. Scagliotti, Irene Persano, Elena Trevisi, Elena Parlagreco, Maria Pia Brizzi
Background Neuroendocrine tumors (NETs) include malignancies with different origins, clinical presentations and prognosis. Synchronous or metachronous ocular metastases from NET are extremely rare. The diagnostic algorithm and the management of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4a9fb0c241582242fa31c8ab4f66c0
http://hdl.handle.net/2318/1785580
http://hdl.handle.net/2318/1785580
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 32, Iss 1, Pp 1-6 (2020)
BackgroundEndometrial carcinoma is one of the most common female cancers in developed countries. Disease stage is associated with the risk of disease relapse after radical treatment. Typically, the risk of disease relapse peaks at 3 years from local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37faab91bc6ccaedbbcce4ab61aaaabd
http://hdl.handle.net/2318/1785562
http://hdl.handle.net/2318/1785562
Publikováno v:
Mediastinum
Pure red cell aplasia (PRCA) represents one of the most common paraneoplastic syndromes in patients with advanced thymoma. Ciclosporin is a very effective treatment in this condition, and it seems to have also a direct anti-cancer effect. We provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f9d9f88ca55956354321aec4e4334b0
http://hdl.handle.net/2318/1849367
http://hdl.handle.net/2318/1849367
Autor:
Anna Pia, Paola Sperone, Leonardo Muratori, C. Pisano, Soraya Puglisi, Giuseppe Reimondo, Giorgio V. Scagliotti, Anna La Salvia
Introduction:: Adrenocortical carcinoma (ACC) is a rare neoplasm characterized by a high risk of recurrence after radical resection. The role of adjuvant systemic therapy in radically resected patients is unclear. Mitotane, a steroidogenesis inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfea664f621b046cee576843ca1c78ed
http://hdl.handle.net/2318/1785589
http://hdl.handle.net/2318/1785589
Autor:
Rosario F Di Stefano, Clizia Zichi, Silvia Novello, Giorgio V. Scagliotti, Eleonora Ghisoni, Maria Lucia Reale, Francesco Perrone, Annapaola Mariniello, Leonardo Muratori, Elena Trevisi, Gianmarco Leone, Pasquale Lombardi, Emmanuele De Luca, Massimo Aglietta, Cristina Sonetto, Massimo Di Maio, Anna La Salvia, Paolo Bironzo, Daniele Pignataro, Laura Marandino
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 139
Objectives We previously reported that quality of life (QoL) is not included among trial endpoints and QoL results are underreported in a significant proportion of phase III oncology trials. Here we describe QoL adoption, reporting and methodology of
Autor:
Giulia Petroni, Annarosa Arcangeli, Lorenzo Antonuzzo, Gianluca Bartoli, Francesco Di Costanzo, Luca Messerini, Luca Boni, Elena Lastraioli, Leonardo Muratori, Jessica Iorio
Publikováno v:
OncoTargets and therapy
Background The identification of early-stage colorectal cancer (CRC) with high risk of progression is one major clinical challenge, mainly due to lack of validated biomarkers. The aims of the present study were to analyze the prognostic impact of thr